Stocks›Healthcare›ONC

ONC

Beone Medicines Ltd.

NasdaqResearch view

Beone Medicines Ltd. operates in the Pharmaceutical Preparations industry.

$361.65+1.00%

Oct 5 close · 1D EOD · Databento

HealthcarePharmaceutical PreparationsLarge-capSEC EDGAR FY 2025-12-31

What happened

Daily closes · dots are Wire stories

What’s next

Expected around late November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 6, 2025 and Nov 12, 2024, before the open.

Last report

Aug 26, 2026−0.15%

before the open

Last 4, next close

median 4.37% either way

up 2 of 4

Every report since 2024 →Earnings calendar →

DateEventSourceNext close

Aug 26Earnings release, before the open · 8-KSEC EDGARSEC EDGAR ↗−0.15%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

17 big days in a year, and what we hold on each

A big day is a close more than 4.18% from the one before, three times ONC’s median day (1.39%). On 2 of the 17, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±4.18%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayONCWhat we hold that dayGroup (median of 4) · each

1 Oct 9, 2025−4.36%
Before our storiesgroup +0.9%, did not move with it
1Oct 9, 2025−4.36%
Before our stories
+0.9% did not move with itABBV −0.2 · JNJ +0.7 · LLY +1.1 · MRK +1.3
2 Oct 10, 2025−4.68%
Before our storiesgroup −1.0%, did not move with it
2Oct 10, 2025−4.68%
Before our stories
−1.0% did not move with itLLY −2.6 · MRK −1.7 · JNJ −0.2 · ABBV −0.1
3 Nov 11, 2025+4.39%
Before our storiesgroup +2.9%, moved with ONC
3Nov 11, 2025+4.39%
Before our stories
+2.9% moved with ONCMRK +4.8 · ABBV +3.0 · JNJ +2.9 · LLY +2.3
4 Nov 12, 2025+9.84%
Before our storiesgroup +1.8%, did not move with it
4Nov 12, 2025+9.84%
Before our stories
+1.8% did not move with itABBV +3.6 · LLY +3.0 · MRK +0.6 · JNJ +0.3
5 Nov 24, 2025−4.32%
Before our storiesgroup +1.0%, did not move with it
5Nov 24, 2025−4.32%
Before our stories
+1.0% did not move with itABBV −2.9 · LLY +1.0 · JNJ +1.1 · MRK +2.7
6 Jan 7, 2026+4.22%
Before our storiesgroup +2.7%, moved with ONC
6Jan 7, 2026+4.22%
Before our stories
+2.7% moved with ONCABBV +4.2 · LLY +4.1 · JNJ +1.3 · MRK −0.3
7 Jan 9, 2026+5.47%
Before our storiesgroup −1.2%, did not move with it
7Jan 9, 2026+5.47%
Before our stories
−1.2% did not move with itMRK −0.4 · JNJ −0.7 · ABBV −1.8 · LLY −2.0
8 Jan 13, 2026+5.11%
Before our storiesgroup −0.0%, did not move with it
8Jan 13, 2026+5.11%
Before our stories
−0.0% did not move with itJNJ +1.9 · ABBV +0.3 · LLY −0.3 · MRK −0.8
9 Feb 25, 2026−4.54%
Before our storiesgroup −0.9%, did not move with it
9Feb 25, 2026−4.54%
Before our stories
−0.9% did not move with itLLY −1.3 · MRK −1.2 · ABBV −0.7 · JNJ −0.5
10 Feb 26, 2026−8.48%
Resultsgroup −0.8%, did not move with it
10Feb 26, 2026−8.48%
ResultsFirst close after the Feb 26 results filing
−0.8% did not move with itMRK −2.6 · ABBV −1.0 · JNJ −0.7 · LLY −0.7
11 Mar 3, 2026−5.51%
Before our storiesgroup −0.9%, did not move with it
11Mar 3, 2026−5.51%
Before our stories
−0.9% did not move with itMRK −1.3 · LLY −1.0 · JNJ −0.7 · ABBV −0.2
12 Mar 12, 2026−4.55%
Before our storiesgroup −0.7%, did not move with it
12Mar 12, 2026−4.55%
Before our stories
−0.7% did not move with itLLY −2.3 · ABBV −1.0 · JNJ −0.4 · MRK −0.3
13 Mar 31, 2026+4.54%
Before our storiesgroup +1.9%, did not move with it
13Mar 31, 2026+4.54%
Before our stories
+1.9% did not move with itLLY +3.7 · ABBV +2.0 · MRK +1.9 · JNJ +0.8
14 May 6, 2026+5.32%
Resultsgroup −0.3%, did not move with it
14May 6, 2026+5.32%
ResultsFirst close after the May 6 results filing
−0.3% did not move with itMRK +0.4 · LLY −0.2 · JNJ −0.4 · ABBV −0.5
15 Aug 7, 2026+5.60%
Nothing on ONCgroup +0.5%, did not move with it
15Aug 7, 2026+5.60%
Nothing on ONCNo ONC story, brief or results filing in our record that day
+0.5% did not move with itABBV +0.9 · JNJ +0.9 · MRK +0.2 · LLY −0.5
16 Aug 17, 2026+4.33%
Nothing on ONCgroup +0.3%, did not move with it
16Aug 17, 2026+4.33%
Nothing on ONCNo ONC story, brief or results filing in our record that day
+0.3% did not move with itJNJ +0.8 · ABBV +0.3 · LLY +0.3 · MRK +0.1
17 Sep 21, 2026+4.23%
Nothing on ONCgroup +0.6%, did not move with it
17Sep 21, 2026+4.23%
Nothing on ONCNo ONC story, brief or results filing in our record that day
+0.6% did not move with itMRK +1.8 · LLY +1.0 · ABBV +0.2 · JNJ −0.2

A story on the same day is not a cause, and a group move is not proof either. Group: the median of LLY, JNJ, ABBV and MRK that day, the largest companies in ONC’s SEC industry; “moved with ONC” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). ONC reports before the open, so day 1 is that day’s close. Each time, day 6 ended on the same side as day 1.

Reported Nov 6, 2025

day 1+3.41%day 6+14.61%

Reported Feb 26, 2026

day 1−8.48%day 6−16.83%

Reported May 6, 2026

day 1+5.32%day 6+6.41%

Reported Aug 26, 2026

day 1−0.15%day 6−3.88%

Next report: expected early-to-late NovemberEstimated from the dates of its last four results filings. Not announced. Since the Aug 26 report: −4.86%. Four reports is a small sample.

Every report since 2024 →

Each line is ONC’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$40.7B

Revenue$5.3B+40.20%

Net income$286.9M

EPS, diluted$0.19+140.40%

Gross margin87.5%

Operating margin8.4%

Return on equity6.6%

Debt / equity0.20

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$40.7B

Enterprise Value$37.0B

Income$286.9M

Sales$5.3B

Book/sh$2.95

Cash/sh$3.12

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio3.08

Current Ratio3.41

Debt/Eq0.20

EPS (ttm)$0.19

EPS this Y140.4%

EPS past 3/5Y—

Sales past 3/5Y55.7%

EPS Y/Y TTM140.4%

Sales Y/Y TTM40.2%

Shs Outstand1.48B

ROA3.5%

ROE6.6%

ROIC47.7%

Gross Margin87.5%

Oper. Margin8.4%

Profit Margin5.4%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$1.2B

FY21

$1.4B

FY22

$2.5B

FY23

$3.8B

FY24

$5.3B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.2B	$1.4B	$2.5B	$3.8B	$5.3B
Gross Profit	$1.0B	$1.1B	$2.1B	$3.2B	$4.7B
Operating Income	$-1.4B	$-1.8B	$-1.2B	$-568.2M	$447.1M
Net Income	$-1.5B	$-2.0B	$-881.7M	$-644.8M	$286.9M
Diluted EPS	$-1.21	$-1.49	$-0.65	$-0.47	$0.19
Operating Cash Flow	$-1.3B	$-1.5B	$-1.2B	$-140.6M	$1.1B
Free Cash Flow	$-1.6B	$-1.8B	$-1.7B	$-633.3M	$941.7M

Same industry

ONC against four drug peers, a year at 100

ONC is up 4.1% in a year. Merck is up 61.8%, Eli Lilly 36.1%, Johnson & Johnson 35.7% and AbbVie 12.4%. All four did more. Weekly closes, Oct 3, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.

Share this chart

ONC +4.1%. Merck +61.8%, Eli Lilly +36.1%, Johnson & Johnson +35.7%, AbbVie +12.4%. Weekly closes, Oct 3, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in ONC’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

LLY$1.08T JNJ$617.0B ABBV$464.4B MRK$356.0B ABT$168.7B PFE$158.5B VRTX$127.9B BMY$124.9B

Build basket with ONC Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.